Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Philip

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyureaP A Philip, V L Souliotis, A L Harris, et al.
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancersB F El-Rayes, M Zalupski, T Bekai-Saab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 2, 2020
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trialH H Yoon, J C Bendell, F S Braiteh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2016
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trialH H Yoon, J C Bendell, F S Braiteh, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJ Alvarez, Q Shi, A Dasari, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyureaP A Philip, V L Souliotis, A L Harris, et al.
British Journal of Cancer|July 17, 1998
Phase I study of the mitomycin C analogue BMS-181174V M Macaulay, K J O'Byrne, J A Green, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancersB F El-Rayes, M Zalupski, T Bekai-Saab, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 2, 2020
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trialH H Yoon, J C Bendell, F S Braiteh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2016
Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trialH H Yoon, J C Bendell, F S Braiteh, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancerJ Alvarez, Q Shi, A Dasari, et al.
Pageof 7